1. Home
  2. BVS vs SPRY Comparison

BVS vs SPRY Comparison

Compare BVS & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$9.29

Market Cap

716.8M

Sector

Health Care

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.07

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
SPRY
Founded
2011
2015
Country
United States
United States
Employees
N/A
159
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.8M
788.5M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
BVS
SPRY
Price
$9.29
$8.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.00
$40.00
AVG Volume (30 Days)
460.6K
1.7M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
N/A
EPS
0.04
N/A
Revenue
$568,087,000.00
$84,278,000.00
Revenue This Year
$7.52
$87.40
Revenue Next Year
$7.06
$81.64
P/E Ratio
$238.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.81
$6.66
52 Week High
$11.25
$18.63

Technical Indicators

Market Signals
Indicator
BVS
SPRY
Relative Strength Index (RSI) 38.74 49.40
Support Level $8.13 $7.82
Resistance Level $11.00 $8.61
Average True Range (ATR) 0.65 0.55
MACD -0.14 -0.04
Stochastic Oscillator 5.33 42.91

Price Performance

Historical Comparison
BVS
SPRY

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: